Ra Medical Systems, Inc. (NYSE: RMED) Loss Submission Form

Kuznicki Law is investigating the proposed merger of Ra Medical Systems, Inc. (NYSE: RMED (“the Company”) with Catheter Precision, Inc. pursuant to which Ra Medical shareholders will own approximately 20% of the combined company, on a fully diluted basis calculated using the treasury stock method, subject to certain adjustments. Kuznicki Law is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.